Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Pathologie-Biologie|June 30, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)]D Blaise, S Nguyen, J-O Bay, et al.
Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Bone Marrow Transplantation|October 27, 2015
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working PartiesO Penack, G Tridello, J Hoek, et al.
Leukemia|March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75J Reiffers, F Huguet, A M Stoppa, et al.
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Leukemia|April 28, 2006
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)F E Nicolini, S Corm, Q-H Lê, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2011
Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patientsM Michallet, T Bénet, M Sobh, et al.
Leukemia & Lymphoma|July 16, 2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapyX Thomas, Qh Le, S de Botton, et al.
Pageof 16